SMi Source lesson Oncology: Sarcoma has the following microlearning topics
1. Learning Objectives
2. Introduction: Sarcomas
3. Introduction: Soft Tissue and Bone Sarcomas
4. Introduction
5. Anatomy and Pathophysiology: Soft Tissue Sarcomas
6. Anatomy and Pathophysiology: Sites of Origin
7. Anatomy and Pathophysiology: GIST
8. Gastrointestinal Stromal Tumor (GIST)
9. STSs: Mechanisms of Disease Development and Progression
10. Anatomy and Pathophysiology: Mechanisms of Disease Development and Progression
11. Anatomy and Pathophysiology: Genetic Considerations - Frequent Chromosomal Translocations in Sarcomas
12. Anatomy and Pathophysiology: Genetic Considerations - Germline Mutations
13. Anatomy and Pathophysiology: Li-Fraumeni syndrome
14. Anatomy and Pathophysiology: Familial Predisposition
15. Clinical Presentation and Diagnoses: Epidemiology and Statistics
16. Clinical Presentation and Diagnoses: STS with Painless Mass
17. Clinical Presentation and Diagnoses: Regional Lymph Nodes
18. Clinical Presentation and Diagnoses: Imaging
19. Clinical Presentation and Diagnoses: Biopsy and Biomarkers
20. Clinical Presentation and Diagnoses: Biomarkers
21. Clinical Presentation and Diagnoses: Staging
22. Soft Tissue Sarcomas (STSs): Current Treatments
23. Current Treatments: Soft Tissue Sarcomas (STSs)
24. Current Treatments: Soft Tissue Sarcomas Radiotherapy
25. Current Treatments: Adjuvant and Neoadjuvant Chemotherapy
26. Current Treatments: Chemotherapy - Additional Cycles
27. Current Treatments: Systemic Individual and Combination Chemotherapeutic Agents
28. Current Treatments: Soft Tissue Sarcomas (STSs)
29. Current Treatments: Visceral Disease
30. Current Treatments: Gastrointestinal Stromal Tumors (GIST)
31. Current Treatments: Desmoid Sarcoma
32. Investigational Treatment Strategies
33. Investigational Treatment Strategies: Novel Routes of Drug Delivery and Combination Therapies
34. Investigational Treatment Strategies: Novel Chemotherapies
35. Investigational Treatment Strategies: Antiangiogenic Therapies
36. Investigational Treatment Strategies: m-TOR
37. Investigational Treatment Strategies: Tyrosine Kinase Inhibitors
38. Investigational Treatment Strategies: Targeted Molecular Therapies
39. Investigational Treatment Strategies: Soft Tissue Sarcoma Investigational Trials
40. Foundational Clinical Trials: Interpretation of Clinical Data
41. Foundational Clinical Trials: Limb-Sparing Surgery
42. Foundational Clinical Trials: Surgery and Radiotherapy
43. Foundational Clinical Trials: Adjuvant Radiotherapy
44. Foundational Clinical Trials: Adjuvant Chemotherapy (SMAC)
45. Foundational Clinical Trials: Adjuvant Chemotherapy - Survival
46. Foundational Clinical Trials: Adjuvant Chemotherapy - GIST
47. Foundational Clinical Trials: Resistance to Imatinib
48. Foundational Clinical Trials: Neoadjuvant Chemotherapy
49. Foundational Clinical Trials: Summary of Foundational Studies
50. Anatomy and Pathophysiology: Osteosarcoma
51. Anatomy and Pathophysiology: Cellular Classification - Osteosarcoma
52. Anatomy and Pathophysiology: Cellular Classification - Ewing Sarcoma
53. Anatomy and Pathophysiology: Hereditary
54. Anatomy and Pathophysiology: Osteosarcoma
55. Clinical Presentation and Diagnoses: Bone Sarcomas
56. Clinical Presentation and Diagnoses: Clinical Presentation and Evaluation
57. Clinical Presentation and Diagnoses: Physical Examination, Imaging and Biopsy
58. Clinical Presentation and Diagnoses: Bone Biopsy
59. Clinical Presentation and Diagnoses: AJCC Staging
60. Current Treatments: Osteosarcoma - Amputation and Survival
61. Current Treatments: Osteosarcoma - Chemotherapy
62. Current Treatments: Osteosarcoma - Summary
63. Current Treatments: Ewing Sarcoma - Reccomendation
64. Current Treatments: Ewing Sarcoma - Summary
65. Current Treatments: Chondrosarcoma
66. Novel Approaches to Bone Sarcoma
67. Investigational Treatment Strategies: Bone Sarcoma
68. Investigational Treatment Strategies: Selected Investigational Trials
69. Foundational Clinical Trials: Osteosarcoma - Aggressive Preoperative Chemotherapy
70. Foundational Clinical Trials: Osteosarcoma - Survival Rates
71. Foundational Clinical Trials: Incorporating Ifosfamide
72. Foundational Clinical Trials: Ewing Sarcoma
73. Foundational Clinical Trials: Chondrosarcoma
74. Sarcomas: Conclusions and Future Directions
75. Sarcomas: Therapy Key Points
